Epidermal growth factor receptor family members (EGFR and HEr2) are prognostic markers and potential therapeutic targets in prostate cancer

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2006年 / 5卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：161 / 161
页数：1
相关论文
共 50 条
  • [21] Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer
    García, I
    Vizoso, F
    Martín, A
    Sanz, L
    Abdel-Lah, O
    Raigoso, P
    García-Muñiz, JL
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (03) : 234 - 241
  • [22] Clinical Significance of the Epidermal Growth Factor Receptor and HER2 Receptor in Resectable Gastric Cancer
    I. García
    F. Vizoso
    A. Martín
    L. Sanz
    O. Abdel-Lah
    P. Raigoso
    J. L. García-Muñiz
    Annals of Surgical Oncology, 2003, 10 : 234 - 241
  • [23] Distinct expression and prognostic value of members of the epidermal growth factor receptor family in ovarian cancer
    Zhou, Quan
    Hou, Chao-Nan
    Yang, Huai-Jie
    He, Ze
    Zuo, Man-Zhen
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6937 - 6948
  • [24] A human epidermal growth factor receptor 3 (HER3)-binding nanoparticle targets and kills Herceptin®-resistant human epidermal growth factor receptor 2 (HER2)-positive breast cancer
    Sims, J. D.
    Taguaim, M.
    Hanson, C.
    Cui, X.
    Medina-Kauwe, L. K.
    CANCER RESEARCH, 2013, 73
  • [25] Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: Quantitative analysis of HER2 overexpression effects
    Hendriks, BS
    Opresko, LK
    Wiley, HS
    Lauffenburger, D
    CANCER RESEARCH, 2003, 63 (05) : 1130 - 1137
  • [26] Epidermal growth factor receptor (EGFR) and Src as therapeutic targets in triple negative breast cancer (TNBC)
    Canonici, A.
    Browne, A.
    Ibrahim, M.
    Fanning, K.
    Roche, S.
    Conlon, N.
    O'neill, F.
    Meiller, J.
    Cemona, M.
    Morgan, C.
    Hennessy, B.
    Solca, F.
    Crown, J.
    O'donovan, N.
    Eustace, A.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E133 - E133
  • [27] Preoperative plasma HER2 and epidermal growth factor receptor for staging and prognostication in patients with clinically localized prostate cancer
    Shariat, Shahrokh F.
    Bensalah, Karim
    Karam, Jose A.
    Roehrborn, Claus G.
    Gallina, Andrea
    Lotan, Yair
    Slawin, Kevin M.
    Karakiewicz, Pierre I.
    CLINICAL CANCER RESEARCH, 2007, 13 (18) : 5377 - 5384
  • [28] Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer
    Siena, S.
    Sartore-Bianchi, A.
    Marsoni, S.
    Hurwitz, H. I.
    McCall, S. J.
    Penault-Llorca, F.
    Srock, S.
    Bardelli, A.
    Trusolino, L.
    ANNALS OF ONCOLOGY, 2018, 29 (05) : 1108 - 1119
  • [29] Prevalence and prognostic significance of HER2/neu and epidermal growth factor receptors in ovarian cancer
    Devitt, JL
    Chew, K
    Sauter, G
    Waldman, F
    Benz, CC
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1995, 14 (04) : 329 - 334
  • [30] Plasma HER2 and EGFR levels are prognostic factors in patients with prostate cancer
    Nature Clinical Practice Oncology, 2008, 5 (2): : 64 - 65
12345